abcnews.go.com
Clearer Drug Risk Information in Ads
New FDA rules require clearer explanations of prescription drug risks and side effects in advertisements, addressing concerns about manipulative practices and the rise of online drug promotion by influencers.
English
United States
Us PoliticsHealthRegulationsFdaAdvertisingDrugs
U.s. Food And Drug AdministrationIspot.tvDuke UniversityIndiana UniversityUniversity Of Colorado Boulder
Tony CoxRuth DayTorrey CopeDick DurbinMike Braun
- When do the new FDA advertising rules become binding?
- The rules, effective November 20, require simple, consumer-friendly language without medical jargon or distracting visuals, addressing concerns about manipulative advertising techniques that obfuscate risk information.
- What concerns exist about the implementation of the new rules?
- While the rules are a step forward, concerns remain about the potential for companies to downplay risks by using on-screen text alongside audio descriptions, leaving it to the companies to decide on the extent of text displayed.
- What are the new FDA rules regarding prescription drug advertising?
- The new FDA rules mandate clearer and more direct explanations of prescription drug risks and side effects in advertisements, aiming to eliminate industry practices that downplay or distract viewers from this crucial information.
- What is the significance of the rise of pharmaceutical influencers promoting drugs online?
- A new trend of pharmaceutical influencers promoting drugs online with little oversight has emerged, prompting a bill in Congress to give the FDA more authority to regulate such promotions on social media.
- What regulatory challenges are posed by the use of social media and telehealth platforms for drug promotion?
- Beyond television advertising, the growing use of social media influencers and telehealth companies to promote drugs raises additional regulatory challenges, as current FDA regulations primarily focus on drug manufacturers.